medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2006, Número 4

<< Anterior Siguiente >>

Dermatología Cosmética, Médica y Quirúrgica 2006; 4 (4)


Eritema multiforme

Asz-Sigall D, López-García L, Rojas-García P, Vega-Memije ME, Arenas R

Idioma: Español
Referencias bibliográficas: 73
Paginas: 268-277
Archivo PDF: 604.52 Kb.


RESUMEN

El eritema multiforme (EM) es una reacción de hipersensibilidad desencadenada por agentes infecciosos (virus del herpes simple) y medicamentos. Clínicamente se caracteriza por pápulas, pústulas, vesículas, placas urticarianas y lesiones en blanco de tiro o “diana” que predominan en codos, rodillas, palmas y plantas. Se puede clasificar en EM menor cuando el cuadro es leve, autolimitado y con un mínimo daño a mucosas y EM mayor cuando es grave, con necrosis mucocutánea extensa y tendencia a progresar al síndrome de Stevens-Johnson (SSJ). La separación entre las formas mayor y menor continúa siendo controvertida ya que algunos autores consideran a la variante mayor como sinónimo del SSJ mientras que otros los describen como dos entidades distintas.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Torres V, Camacho F, Mihm M et al. Dermatología práctica Ibero- Latinoamericana. Atlas, enfermedades sistémicas asociadas y terapéutica. México Imprelibros 2005: 469-473

  2. Arenas R. Dermatología. Atlas, diagnóstico y tratamiento. México Interamericana McGraw Hill 2004: 336-351

  3. Ayangco L, Rogers R. Oral manifestations of erythema multiforme. Dermatologic Clinics 2003; 21: 195-205

  4. Rappersberger K, Foedinger D. Treatment of erythema multiforme, Stevens- Johnson Syndrome and Toxic Epidermal Necrolysis. Dermatology Therapy 2002; 15: 397-408

  5. Farthing P, Bagan J-V, Scully. Erythema multiforme. Oral Diseases 2005; 11: 261-267

  6. Johnston GA, Ghura HS, Carter E et al. Neonatal erythema multiforme major. Clinical Dermatology 2002; 27: 661-664

  7. Forman R, Koren G, Shear N. Erythema Multiforme, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children. Drug Safety 2002; 25 (13): 965-972

  8. Léauté-labrèze C, Laminreau T, Chawki D et al. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson Syndrome. Archives of Disease in Childhood 2000; 83: 347-352

  9. Malo A, Kâmpgen E, Wank R. Recurrent Herpes Simples Virus-Induced Erythema Multiforme: Different HLA-DQB1 Alleles Asóciate with Severe Mucous Membrana Versus Skin Attaks. Scandinavian Journal of Inmunology 1998; 47: 408-411

  10. Kokuba H, Imafuku S, huang S et al. Erythema multiforme lesions are associated with expression of a herpes simplex virus (HSV) gene and qualitative alterations in the HSV-specific T-cell response. British Journal of Dermatology 1998; 138: 952-964

  11. Bateman T. A practical synopsis of cutaneous diseases. London: Longman, Hurst, Reese and Brown, 1814

  12. Rayer PF. Traité des maladies de la peau. Paris, 1835 (Cit. en 1)

  13. Saúl A. Lecciones de Dermatología. México Méndez Editores 2001: 455

  14. Von Hebra F, Kaposi M. On diseases of the skin including exantemas. Vol 1. London: New Sydenham Society, 1866; 449-494 (Cit. en 1)

  15. Hebra F, Kaposi M. On diseases of the skin including the exantemata. London: New Sydenham Society, 1875; 1-274 (Cit. en 1)

  16. Von Hebra F. Acute exantheme und hautkranheiten. Handbuch der Speciellen Pathologie und Therapie. Erlangen: Verlag von Ferdinand von Enke, 1860: 198-200 (Cit. en 28)

  17. Von Hebra F. On diseases of the skin, including the exanthemata. Fagge CH, ed London: The New Sydenham Society, 1866: 285 (Cit. en 28)

  18. Urman F, Weinberg J. Scary eruptions but usually a mild disease: Erythema Multiforme. www.dermatlas.com

  19. Stevens AM, Johnson FC. A new eruptive fever associated with stomatitis and ophtalmia. Am J Dis Child 1992; 24: 526-533

  20. 20.Thomas BA. The so-called Stevens Johnson Syndrome. BMJ. 1950; 1: 1393- 1397

  21. Brice SL, Huff JC, Weston WL. Erythema multiforme. Curr Probl Dermatol 1990; II: 3-26

  22. Volcheck GW. Clinical evaluation and management of drug hypersensitivity. Immunol Allergy Clin N Am 2004; 24: 357-371

  23. Rzan B, Mokhenhaupt, Baur S et al. Epidemiology of Erythema exudativum multiforme majus, Stevens-Johnson syndrome, and Toxic epidermal necrolysis in Germany (1990-1992): Structure and results of a population based registry. J Clin Epidemiol 1996; 49: 749-773

  24. 24.Mockenhaupt M, Schopf E. Epidemiology of dug induced severe skin reactions. Sem Cutan Med Surg 1996; 15: 236-243

  25. Stingeni L, Caraffini S, Assalve D et al. Erythema multiforme-lilce contact dermatitis from budesonide. Contact Dermatitis 1996; 34: 154-155

  26. 26.Gattomo M, Picco P, Gambim C et al. Erythema multiforme-like manifestation and arthritis in 3 year old child with leukocytolastic vasculitis. Clin Exp Rheumatol 1997; 15: 329-332

  27. Muñoz D, Del Pozo MD, Audicana M et al. Erythema multiforme-like eruption from antibiotics of 3 different groups. Contact dermatitis 1996: 34: 227-228

  28. Bolognia J, Jorizzo J, Rapini R et al. Dermatology. Elsevier 2004: 313-216

  29. 29.Weston WL, Brice SL, Jester JD et al. Herpes simplex virus in childhood erythema multiforme. Pediatrics 1992; 89: 32-34

  30. 30.Weston WL, Morelli JG. Herpes simplex virus-associated erythema multiforme in prepubertal children. Arch Dermatol Res 1993; 128: 542-545

  31. Brice SL, Stockert SS, Bunker LD et al. The herpes-specific immune response of individuals with herpes-associated erythema multiforme compared with that of individuals with recurrent herpes labiales. Arch Dermatol Res 1993; 285: 193-196

  32. Schofield JK, Tatnall FM, Leigh IM. Recurrent erythema murliforme: clinical features and treatment in a large series of patients. Br J Dermatol 1993; 128: 542-545

  33. Schoenfield JK, Tanall FM, Leighl IM. Recurrent erythema mulriforme: Clinical features and treatment on a large series of patients. Br J Dermatol 1993; 542-545 34.Weston EL, Brice SL, Jester JD. Herpes simplex vius in a childhood erythema multiforme. Pediatrics 1992; 89: 32-34

  34. Di Lerina V, Lo-Scocco G, Bisiginni G. Erythema multiforme following hepatitis B vaccine. Pediatr Dermatol 1994; 11: 363-364

  35. Drago F, Parodi A, Rebora A. Persistent erythema multiforme: Report of two new cases an review of the literature. J Am Acad Dermatol 1995; 33: 366-369

  36. Larcher C, Gasser A, Hattmannstorfer R et al. Interaction of HSV-1 Infected Peripheral Blood Mononuclear Cells with Cultured Dermal Microvascular Endothelial Cells: a Potential Model for the Pathogenesis of HSV-1 induced Erythema Multiforme. The Journal of Investigative Dermatology 2001; 116 (1): 150-156

  37. Ng P, Jiang Y, Hee H et al. Detection of Herpes simplex Virus Genomic DNA in Various Subsets of Erythema mutliforme by Polymerase Chain Reaction. Dermatology 2003; 207: 349-353

  38. Seishima M, Oyama Z, Yamamura M. Erythema multiforme Associated with Citomegalovirus Infection in Nonimmunosuppressed Patients. Dermatology 2001; 203: 299-302 40.Assier H, Bastuji-Garin S, Revuz J et al. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol 1995; 131 (5): 539-543

  39. Roujeau JC. Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme. J Dermatol 1997; 24 (11): 726-729

  40. Pruksachatkunakorn C. Erythema multiforme. Emedicine 2005

  41. Scofield JK, Tatnal FM, Brown J et al. Recurrent erythema multiforme: Tissue typing in a large series of patients. Br J Dermatol 1994; 131: 532-535

  42. 44.Rasmussen J. Erythema Multiforme: a Practical Approach to Recent Advances. Pediatric Dermatology 2002; 19 (1): 82-84

  43. Kaur S, Thami G, Kanwar A et al. Kikuchi Disease with Facial Rash and Erythema Multiforme. Pediatric Dermatology 2001; 18 (5): 403-405

  44. 46.Kokuba H, Aurelian L, Burnett J. Herpes Simplex Virus Associated Erythema Multiforme (HAEM) is Mechanistically Distinct from Drug-Induced Erythema Mutliforme: Interferon – Á is expressed in HAEM Lesions and Tumor Necrosis Factor in Drug-Induced Erythema Multiforme Lesions. The Journal of Investigative Dermatology 1999; 113 (5): 808-815

  45. Chrysomaly E, Lozada-Nur F, Dekker N et al. Apoptosis in oral erythema. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics 1997; 83 (2): 272-280

  46. Brice SL, Stockert SS, Bunker JD et al. The herpes-specific imune response of individuals with herpes-associated erythema multiforme compared with that of individuals with recurrent herpes labialis. Arch Dermat Res 1993; 285: 193-196

  47. 49.Paquet P, Pierard GE. Erythema multiforme and toxic epidermal necrolysis: A comparative study. Am J Dermatopathol 1997; 19: 127-132

  48. Darragh TM, Egbert BM, Berger TG et al. Identification of herpes simplex virus DNA in lesions of erythema multiforme by the polymerase chain reaction. J Am Acad Dermatol 1991; 24: 23-26

  49. Weston WL. What is erythema multiforme? Pediatr Ann 1996; 25: 106-109

  50. Dikland WJ, Oranje AP, Stolz E et al. Erythema multiforme un childhood and early infancy. Pediatr Dermatol 1986; 3: 135-139

  51. Huff JC, Weston WL. Recurrent erythema multiforme in childhood and early infancy. Pediatr Dermatol 1986; 3: 135-139

  52. Huff JC, Eston WL. Isomorphic phenomenon in erythema multiforme. Clin Exp Dermatol 1983; 8: 409-413

  53. Farthing PM, Maragou P, Coates M et al. Characteristics of the oral lesions in patients with cutaneous recurrent erythema multiforme. J Oral Pathol Med 1995; 24: 9-11 56.Weston WL, Brice SL. Atypical forms of herpes simplex associated erythema mutliforme. J Am Acad Dermatol 1998; 39: 124-126

  54. Lozada-Nur F, Gorsky M, Silverman S Jr. Oral erythema multiforme: clinical observations and treatment of 95 patients. Oral Surg Oral Med Oral Pathol 1998; 67: 36-40

  55. Howland WW, Golitz LE, Huff JC et al. Erythema multiforme: clinical, histopathologic and immunologic study. J Am Acad Dermatol 1984; 10: 438-446

  56. Tatnall FM, Schofield JK, Leigh IM. A double-blind, placebo-controlled trial os continous acyclovir therapy in recurrent erythema multiforme. Br J Dermatol 1995; 132: 267-270

  57. 60.Wolf P, Soyer HP, Fink-Puches R et al. Recurrent post-herpetic erythema multiforme mimicking polymorphic light and juvenile spring eruption: report of two cases in young boys. Br J Dermatol 1994; 131: 364-367

  58. Revuz J. New advances in severe adverse drugs reactions. Dermatologic Clinics 2001; 19 (4)

  59. 62.Ackerman B. Histologic diagnosis of inflamatory skin diseases. Williams & Wilkins 1997: 352-654

  60. Ono F, Sharma B, Smith C et al. CD34+ Cells in the Peripheral Blood Transport Herpes Simplex Virus DNA Fragments to the Skin of Patients with Erythema Multiforme (HAEM). The Journal of Investigative Dermatology 2005; 124: 1215-1224

  61. 64.Paquet P, Pièrard GE. Erythema Multiforme and Toxic Epidermal Necrolysis: a comparative study. The American Journal of Dermatopathology 1997; 19 (2): 127-132

  62. Brice SL, Leahy MA, Ong L et al. Examination of the non-involved skin, previously involved skin and peripheral blood for herpes simplex virus DNA in patients with recurrent herpes associated erythema multiforme. J Cutan Pathol 1994; 21: 408-412

  63. 66.Weston JA, Weston WL. The overdiagnosis of erythema multiforme. Pediatrics 1992; 89: 802

  64. Tamayo- Sanchez L, Ruiz-Madonado R, Lateraza AM et al. Acute annular urticaria in infants and children. Pediatr Dermatol 1997; 14: 231-234

  65. 68.Marinho L, Haj M, Pereira L et al. Lip adhesion: An unusual complication of erythema multiforme. Oral Medicine 1999

  66. 69.Martínez A, Atherton D. High-Dose Systemic Corticosteroids Can Arrest Recurrences of Severe Mucocutaneous Erythema Multiforme. Pediatric Dermatology 2000; 17 (2): 87-90

  67. 70.Orozco-Covarrubias ML, Laterza AM, Tamayo-Sánchez L et al. Edema agudo hemorrágico del lactante (púrpura en escarapela). Med Cutan Ibero Lat Am 1990; 18: 392-396

  68. Tanall FM, Schoield JK, Leigh IM. A double blind placebo controlled trial of continuos acyclovir therapy in recurrent erythema multiforme. Br J Dermatol 1995; 132: 267-270

  69. Spurance SL, Tyring SK, De Gregorio B et al. A large-scale, placebocontrolled, dose-ranging trial of perioral valacyclovir for episodic treatment of recurrent herpes genitalis. Arch Intern Med 1996; 156: 1729-1735

  70. Duhra P, Paul CJ. Continous eritema multiform clearing on dapsone. Br J Dermatol 1988; 118: 731

  71. Rusell JR. Azathioprine therapy in the management of persistent erythema multiforme. Br J Dermatol 1989; 105: 456-458

  72. Cherovati K, Souteyrand P et al. Treatment par thalidomide de l´erytheme polymorphic chronique fome recidivant et subintrate. Etude rétrospective de 26 malades. Ann Dermatol Veneorol 1996; 123: 375-377

  73. Bysterin JC. Erythema multiforme with mucous membrane involvement and Stevens-Johnson Syndrome are clinically different disoirders. Arch Dermatol 1996; 711: 12 Volumen 4 / Número




2020     |     www.medigraphic.com